| 查看: 2434 | 回复: 7 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
starlogo银虫 (正式写手)
|
[求助]
求science投稿的cover letter模板
|
||
|
感觉要求的内容很多 不知道谁能分享一个模板？ 谢谢 |
回复此楼» 收录本帖的淘帖专辑推荐
 个人收集的一些帖子 |
» 猜你喜欢
自荐读博
已经有3人回复
-
求助:我三月中下旬出站，青基依托单位怎么办？
已经有5人回复
-
论文终于录用啦！满足毕业条件了
已经有22人回复
-
不自信的我
已经有5人回复
-
磺酰氟产物，毕不了业了！
已经有4人回复
-
投稿Elsevier的杂志（返修），总是在选择OA和subscription界面被踢皮球
已经有8人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 谁那儿有cover letter 的模板？？
已经有5人回复
- Analytical Sciences投稿求助
已经有15人回复
- COVER LETTER（投稿信）实用指南
已经有42人回复
- 急求JPCC 投稿的cover letter模板~~
已经有5人回复
【答案】应助回帖
starlogo(金币+10): 2011-09-29 21:46:32
|
Dear , I would like to submit the manuscript entitled, “Key interactions of the mutant HIV-1 Reverse Transcriptase/Efavirenz: An evidence obtained from ONIOM method” to be published in MedChemComm. The main objective of this work is to find out the key residues in the binding site of the HIV-1 reverse transcriptase, bound with its inhibitor, based on the ONIOM method. This method has been applied to large biological system, but, still focused on the drug-enzyme interaction, calculated at high level of calculations. The obtained results indicate structural and energetic properties of the key residues (L101 and S105) which are important for the design of novel inhibitor, against mutant enzyme. This manuscript may be interesting to MedChemComm readers. It would be very kind, if you could consider this manuscript to be published in MedChemComm. I certify that this manuscript, or any part of it, has not been published and will not be submitted elsewhere for publication while being considered by the journal MedChemComm. May I ask for your kind consideration for this purpose? I am very appreciated by your kindness. Looking forward to hearing from you. Sincerely yours, |
6楼2011-09-29 08:24:37